These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38190275)

  • 1. The World Health Organization Reporting System for Pancreaticobiliary Cytopathology.
    Pitman MB
    Arch Pathol Lab Med; 2024 Jan; ():. PubMed ID: 38190275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The World Health Organization Reporting System for Pancreaticobiliary Cytopathology.
    Pitman MB; Centeno BA; Reid MD; Siddiqui MT; Layfield LJ; Perez-Machado M; Weynand B; Stelow EB; Lozano MD; Fukushima N; Cree IA; Mehrotra R; Schmitt FC; Field AS
    Acta Cytol; 2023; 67(3):304-320. PubMed ID: 36516741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A brief review of the WHO reporting system for pancreaticobiliary cytopathology.
    Pitman MB; Centeno BA; Reid MD; Saeig M; Siddiqui MT; Layfield LJ; Perez-Machado M; Weynand B; Stelow EB; Lozano MD; Fukushima N; Cree IA; Mehrotra R; Schmitt FC; Field AS
    J Am Soc Cytopathol; 2023; 12(4):243-250. PubMed ID: 37003924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of malignancy and overall survival associated with the diagnostic categories in the World Health Organization Reporting System for Pancreaticobiliary Cytopathology.
    Hsiao WY; Wang Q
    Cancer Cytopathol; 2024 Oct; 132(10):635-645. PubMed ID: 38944695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of malignancy associated with diagnostic categories of the proposed World Health Organization International System for Reporting Pancreaticobiliary Cytopathology.
    Hoda RS; Arpin RN; Rosenbaum MW; Pitman MB
    Cancer Cytopathol; 2022 Mar; 130(3):195-201. PubMed ID: 34623767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The World Health Organization Reporting System for Pancreaticobiliary Cytopathology: Overview and Summary.
    Centeno BA; Saieg M; Siddiqui MT; Perez-Machado M; Layfield LJ; Weynand B; Reid MD; Stelow EB; Lozano MD; Fukushima N; Cree IA; Mehrotra R; Schmitt FC; Field AS; Pitman MB
    Cancer Cytopathol; 2024 Jul; 132(7):396-418. PubMed ID: 38709670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Malignancy Using the Diagnostic Categories Proposed by the World Health Organization International System for Reporting Pancreaticobiliary Cytopathology.
    Gocun PU; Simsek B; Ekinci O; Ekmen N; Arhan M; Karakan T; Ibis M; Cindoruk M
    Acta Cytol; 2022; 66(6):475-485. PubMed ID: 35732161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of malignancy in the categories of the Papanicolaou Society of Cytopathology system for reporting pancreaticobiliary cytology.
    Hoda RS; Finer EB; Arpin RN; Rosenbaum M; Pitman MB
    J Am Soc Cytopathol; 2019; 8(3):120-127. PubMed ID: 31097287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Performance of Bile Duct Brush Cytology with Risk of Malignancy of Standardized Categories in the Wake of World Health Organization Reporting System for Pancreaticobiliary Cytopathology: An Updated Systematic Review and Meta-Analysis.
    Rath A; Pradeep I; Nigam JS
    Acta Cytol; 2023; 67(6):639-649. PubMed ID: 37879315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on risk stratification in the Papanicolaou Society of Cytopathology System for Reporting Pancreaticobiliary Cytology categories: 3-Year, prospective, single-institution experience.
    Sung S; Del Portillo A; Gonda TA; Kluger MD; Tiscornia-Wasserman PG
    Cancer Cytopathol; 2020 Jan; 128(1):29-35. PubMed ID: 31722125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility assessment of WHO reporting system for pancreaticobiliary cytopathology: A single institution experience.
    Selvaraj S; Dharmalingam P; Alashetty S; Patil A
    Diagn Cytopathol; 2024 Nov; 52(11):617-626. PubMed ID: 38860686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience and future perspectives on the use of the Papanicolaou Society of Cytopathology Terminology System for reporting pancreaticobiliary cytology.
    Saieg M; Pitman MB
    Diagn Cytopathol; 2020 May; 48(5):494-498. PubMed ID: 32031332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of Pancreatic Cytology with the Papanicolaou Society of Cytopathology System: A Systematic Review, before Shifting into the Upcoming WHO International System.
    Nikas IP; Proctor T; Seide S; Chatziioannou SS; Reynolds JP; Ntourakis D
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of malignancy associated with the diagnostic categories proposed by the Papanicolaou Society of Cytopathology for pancreaticobiliary specimens: An institutional experience.
    Gonzalez-Mancera MS; Ahmadian SS; Gomez-Fernandez C; Velez-Torres J; Jorda M; García-Buitrago MT
    Diagn Cytopathol; 2022 Feb; 50(2):49-56. PubMed ID: 34856075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rationale for the development and publication of the World Health Organization reporting systems for cytopathology and a brief overview of the first editions of the lung and pancreaticobiliary systems.
    Field AS; Pitman M; Cree IA; Canberk S; Bubendorf L; Mahrotra R; Schmitt F
    Cancer Cytopathol; 2023 Dec; 131(12):751-761. PubMed ID: 37702127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic sensitivity and risk of malignancy for bile duct brushings categorized by the Papanicolaou Society of Cytopathology System for reporting pancreaticobiliary cytopathology.
    Layfield LJ; Zhang T; Esebua M
    Diagn Cytopathol; 2022 Jan; 50(1):24-27. PubMed ID: 34800330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytology Reporting System for Lung Cancer from the Japan Lung Cancer Society and the Japanese Society of Clinical Cytology: An Extensive Study Containing More Benign Lesions.
    Yoshizawa A; Hiroshima K; Takenaka A; Haba R; Kawahara K; Minami Y; Kakinuma H; Shibuki Y; Miyake S; Kajio K; Kiyonaga K; Nagatomo M; Nishimura S; Mano M; Matsubayashi J; Motoi N; Nagao T; Nakatsuka SI; Yoshida T; Satoh Y
    Acta Cytol; 2022; 66(2):124-133. PubMed ID: 34872081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytologic Categorization with Risk Stratification of Endoscopic Ultrasound-Guided Fine Needle Aspiration from Pancreatic Lesions Based on Guidelines of the Papanicolaou Society of Cytopathology: 12-Year Tertiary Care Experience.
    Nishith N; Rao RN; Rai P
    Discoveries (Craiova); 2021; 9(3):e134. PubMed ID: 34816002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The World Health Organization Reporting System for Lung Cytopathology.
    Schmitt FC; Bubendorf L; Canberk S; Chandra A; Cree IA; Engels M; Hiroshima K; Jain D; Kholová I; Layfield L; Mehrotra R; Michael CW; Osamura R; Pitman MB; Roy-Chowdhuri S; Satoh Y; VanderLaan P; Zakowski MF; Field AS
    Acta Cytol; 2023; 67(1):80-91. PubMed ID: 36509066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papanicolaou society of cytopathology system for reporting pancreaticobiliary cytology: Risk stratification and cytology scope - 2.5-year study.
    Ilyas AM; Bohra M; More NM; Naik LP
    Cytojournal; 2022; 19():33. PubMed ID: 35673695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.